Elizabeta Zisovska, Skopje, Republic of Macedonia

Size: px
Start display at page:

Download "Elizabeta Zisovska, Skopje, Republic of Macedonia"

Transcription

1 Elizabeta Zisovska, Skopje, Republic of Macedonia The comments are extracted and supported by the Drug register (for registered drugs in Republic of Macedonia) issued by the ministry of health, Republic of Macedonia General comments: 1. For children, the dosage should be adjusted according to the body weight, i.e. mg/kg, because of the different proportion weight/age. ). It is more difficult to prescribe the doses/m 2 (it needs nomogram and calculations ) 2. Recommendation: the dosage should be determined for a single dose, i.e. mg/kg/dose, and to determine the number of doses and the time interval between the doses, depending of the medicament and its elimination (for example: mg/kg/dose, 4 times per day, every 6 hours, or drug-mg/kg/dose, 3 times per day, every 8 hours), because of the limited excretion and possible cumulative effect especially in neonates. Sometimes the number of doses have to be restricted compared to the adult ones. Especially in neonatal age the medicines can be even prescribed every 18 hours (for prematures). 3. Specificity of the pediatric patients: -age groups (neonate fullterm and premature, infant, small children, school children, adolescence). in neonatal period the physiological functions which determine the pharmacokinetics are changing very fast, day to day, because of postnatal maturation of kidneys and liver, and also protein contents of body fluids, and all these facts require to determine four groups of neonates: birthweight <2000 grams and <7 days; BW<2000 g and >7 days, neonates with BW>2000 and < 7 days and BW>2000 g and >7 days. 4. Although the pain is a category that is not investigated deeply in neonates and infants, it is recommended to administer pain relief in painful procedures and in postoperative period Specific Comments to the WHO Model list (Draft) 1. Anaestethics 1.1. general anaesthaesia halothane is out of use two years ago 1.2. local anaesthetics their use is preferable as infiltrative anaesthesia in painful procedures, for example intraarticular injections, introduction of intraarterial catheters, punction of bone medulla, stiching Lidocain hidrochlorid, exists Lidocain hydrochlorid for injection amp (40 mg+0,025 mg)/2ml in vial. This mode of labeling the vial maybe is appropriate for easier determination of the prescribed dose of 3 mg/kg, or 7 mg/kg for Lidocain adrenalin (epinephrin) also should be recommended to label the vial (solution pro injectionem) in mg (In Macedonia registered as Lidocain 2% adrenalin 40 mg + (0,025 mg/2 ml) and is probably easier to prescribe the dosage in mg. For dental anaelgesia for children it is recommended mg of the medicament (1-1,5 ml) preoperative medications to determine the doses for children according to the age or body weight Diazepam-there are other forms of the medicament: tablets of 2 mg, 5 mg and 10 mg; solution for injection 10 mg/2 ml, and suppositories 5 mg and 10 mg for those who vomit 1

2 Morphine solution for injection 4 mg/ml and 20 mg/ml. It could be administered also subcutaneous in dose 0,05-0,2 mg/kg/day divided in 3-4 doses. I agree that it should be determined the dosage for neonates for IM and SC administration. Used as an analgesia and sedation is administered in continuous infusion in dose 10 mcg/kg/hour. Consider its use in the management of neonatal abstinence syndrome. The use and dose of morphine in NAS is titrated according to the severity of drug withdrawal in the infant. This is evaluated using the scores derived from the Finnegan Score Chart. Starting regime - 0.5mg/kg/day given 6th hourly, if not effective may be increased to 0.7mg/kg/day 6th hourly. Maximum dose 0.9mg/kg/day recommended the use of suxamethonium administered to facilitate the endotracheal intubation in infants > 2kg or > 7 days age (guideline only) by producing skeletal muscle relaxation. Vial of 200 mg and 500 mg. Given diluted in dose of 1 mg/kg given as a stat IV dose consider the use of Dormicum (midazolam) for sedation mainly, but it can be used for endotracheal intubation for single use in dose 0,1 mg/kg (bolus dose). Comes in vial 5 mg/5 ml. 2. Analgesics 2.1. non-opioids acetylsalycilic acid. Forms-tablets of 100 mg, 300 mg and 500 mg. Because of the risk of Rey-syndrome, the use in pediatrics is restricted only for children over 12 years, very rare for pain relief in arthralgia, muscle pain and headache. It could be administered also as an antiagregatic medicament. Contraindicated in patients with flu and varicella ibuprofen-there are several other forms: tabl 200 mg, tabl 400 mg, and also oral solution 100 mg/5 ml (contains 100 ml) and crème 1 g (10%) for local use. The dosage for the children depends on the indication: 20 mg/kg/day divided in 3-4 doses, and for juvenile rheumathoid arthritis in dose of 40 mg/kg/day. For children with less of 30 kg, the maximum daily dose is 500 mg. The crème is suitable for children older than 12 years paracetamol: there are several other forms: tablets 500 mg, oral solution 120 mg/5 ml, suppositories of 80 mg, 150 mg, 300 mg and 600 mg (the last two mainly for adults). Dosage: children up to 6 years mg/kg/dose for maximum 4 doses; 6-12 years mg/doses, 3-4 times per day; infants of 3-6 months-suppositories 2-3 times per day supp 80 mg; infants of 7-12 months-150 mg/dose 3-4 times per day opioid analgesics 3. antiallergics and medicines used in anaphylaxis 3.1. dexamethason registered for children in dose of 0,02-0,1 mg/kg/dose, twice per day. Forms: tablets 0,5 mg and vial solutio per injectionem 4 mg/ml 3.2. epinephrine (adrenalin) hydrochlorid-suitable for neonates as well, for treatment of acute circulatory collapse in continuous infusion and with low dosage: mcg/kg/min; High dosage: 0.2-1mcg/kg/min. Adrenalin could be used in bradycardia and hypotension in dose 0,01-0,03 mg/kg/dose and could be repeated every 5 minutes 2-3 times. Also can be administered endotracheally while resuscitating the neonate, and this indication is confirmed and included in the textbooks also 3.3. hydrocortisone-consider its use as adjunct therapy for persistent hypoglycaemia in dose 2-10mg/kg/day / 12th hourly for neonates, infuse over 1 minute as bolus by proximal cannula site injection. Comes in tablets 20 mg; and vials 250 mg/10 ml 2

3 4. antidotes 5. anticonvulsants 5.1. carbamazepine in tablets only of 200 mg. Used in children, the dosage adjusted according to the age (< one year, 1-5 years and > 5 years of age) 5.2. diazepam-forms: tablets 2 mg, 5 mg, 10 mg; suppositories: 5 mg and 10 mg. Consider its rectal use for children who can not take the medicine orally, and the dose should be determined according to the body weight (0,2-0,3 mg/kg/dose) phenobarbital available in forms: tablets of 15 mg and 100 mg and pulvis for solution amp 220 mg/2 ml. There is no oral liquid 5.4. phenytoin-there are only tablets of 100 mg, and is recommended only for children >2 years of age. Difficult for administration because there is no solution for oral use valproic acid-tablets gastroresistant from 150 mg, 300 mg, and 500 mg; oral solution 300 mg/1 ml. For children <15 years suitable dose of mg/kg/dose, 2-3 times per day. 6. anti infective medicines 6.1.anthelmintics intestinal levamisol is not registered mebendazol-tablets of 100 mg and peroral suspension 30 ml (100 mg/5 ml). there are not registered pyrantel, prasinqantel and niclosamid and no registered medicines here, and for review-check the doses for children, especially those <2 years 6.2. antibacterials General comments: It is important to note the growing resistance after long use, and the need for change the antibiotics from the same group, because of it. Also, in neonates and infants to consider the possibility of muscle induration if given IM, and to prefer medicines for IV or SC use. Consider cephalosporines of later generations because of the low resistance, and keep them as monotherapy beta lactams amoxicillin-available Capsules 250 mg and 500 mg, granules for oral liquid 125 mg/5 ml, and 250 mg/5 ml. I don't see need for another form (suggested 12 mg/1,25 ml) amoxiclav-here exists the pediatric suspension (125 mg +31,5 mg)/5 ml, than (250 mg +62,5 mg)/5ml, both for three times per day, and also (400 mg +57 mg)/5 ml for dose twice per day. Check the last form ( ) for children use, because of the toxic effects of the clavulanic acid in small children <1 years ampicillin-there is registered oral liquid 250 mg/5 ml and capsules 250 and 500 mg penicillins-consider administration based on IU/kg, not one of them in IU and the other in mg/kg. Cloxacillin-vial 1 g; capsule 250 mg; oral 125 mg/5 ml; suspension (very suitable for small children) Phenoxymethylpenicillin-only tablets IU. The use in children possible only for those >6 years. Need for oral liquid for younger Procain benzylpenicillin-vial IU and IU 3

4 Ceftriaxon-I agree to be included in core list, as by the guidelines to use it in late onset infections as per antibiogram Imipenem cilastatin-for strict use as per antibiogram if the senzitivity is restricted. Check the use for neonates other antibacterials Chloramphenicol-restrict use only where antibiogram shows sensitivity, but consider dose of 25 mg/kh BW once daily in neonates in the first 7 days, the same dose for premature infants with <2000 g over 7 days, and 50 mg/kg BW given twice daily for neonates older than 7 days. Topical use is not so restricted. Ciprofloxacin-tablets 250 mg, 500 mg, vial of concentrate 100 mg/10 ml, infusion solution 100 mg/50 ml, 400 mg/200 ml. Restricted use for children, only according to the antibiogram if others show resistance Doxycycline (and other tetracyclines) are not used for children <12 years Spectinomycine-I don t t think it is necessary to be included in the list Trimetoprim isolated maybe has no need to be included Sulfonamides restricted for use in the first 7 days of life (because of albumin binding possibility) 6.2.4: Antituberculotics-unfortunately there are difficulties in availability of pediatric formulations All aminoglycozides are second-line medicines for TB 6.3: Antifungal medicines Nystatin-preferably oral solution especially for neonates, in form of 24 ml of /ml solution, ointment 20 g IU/g. Vaginal tablets??? 6.4 Antiviral medicines 6.4.1: Antiherpes-aciclovir oral restricted use only for children >2 years. In neonates, used for treatment of neonatal herpes simplex infections, varicella zoster infections with CNS and pulmonary involvement, and herpes simplex encephalitis Protease inhibitors not registered for children, new policy needed Antimalarial medicines-malaria is eradicated in this region. Only prophylaxis administered for those going in endemic areas 7. Antimigraine medicines: acetylsalicylic acid and propranolol not used for this indications. Only paracetamol indicated 8. antineoplastic drugs-specific protocols in use, and need specific review. 9. palliative care 10. medicines affecting the blood a. iron medicines-salts ferrous sulphate as drops-available b. useful ferrous maltose complex also in oral solution consider the starting period (AAP recommends to start after 40 days in premature neonates), and it will be very useful if the earlier start will be studied (only one study starting ferrous medicine from the 15-th day after the delivery) phytomenadion-reconsider its use in prophylaxis and therapeutic doses in neonates medicines affecting coagulation-reconsider its necessity 11. blood products 4

5 12. cardiovascular medicines-needs specific review of cardiologists because of specific 13. dermatological medicines a. if povidone iodide included, consider its use after TSH-screening performed 14. diagnostic agents 15. disinfectants-what is their role in pediatric treatment? 16. diuretics a. furosemid-solution 20 mg/2 ml and tablets 40 mg, dose 2 mg/kg/day in 2 doses. Consider its use in congestive cardiac failure, prerenal failure and chronic Neonatal Lung Disease b. spironolacton-registered for children, tablets 25 mg and 100 mg; therapy not longer than 30 days c. hydrochlorothiazide-tablets 25 mg and 50 mg; children 2 mg/kg/day 17. gastrointestinal medicine a. ranitidine: solution vial 50 mg/5 ml; 50 mg/2 ml; tablets: 150 mg, 300 mg consider its use in NICU while hypoxia persists and mechanical ventilation performed (stress ulcusses). Used to maintain the gastric ph >4 when infants are nil by mouth and receiving dexamethasone for the management of Bronchopulmonary Dysplasia (BPD). b. laxatives-senna not recommended in children <12 years 18. hormones 19. immunological medicines and vaccines a. there is an immunization calendar specific for each country. Consider creating list of contraindications (general and specific) for each vaccine, especially after administration of blood and blood products and immunomodulating medicines. 20. muscle relaxants 21. ophtalmological preparations a. acyclovir ointment 3% b. consider use after microbiological analysis (eye swab) 22. antioxidants 23. peritoneal dyalisis-specific compositions 24. antipsychotic medicines-specific disorders, and need specific review. Valproic acid belongs to a group of medications called anticonvulsants. Anticonvulsants are used to control seizure disorders, but in psychiatry Valproic Acid may also be used to stabilize mood, especially in Bipolar Disorders. 25. medicines on respiratory tract 26. solutions correcting body fluids-specific guidelines for corrections, according to the disturbances 27. vitamins and minerals a. calcium gluconate maybe could be included in core list? Consider use during exchange transfusion in neonates 5

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS SR. NO 1 ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS Paracetamol 500 mg, Phenylephrine HCL 5 mg With Chlorpheniramine Maleate 2 mg & Caffeine 30 mg Tablets 2 Salbutamol Tablets BP 2 mg 3 Salbutamol Tablets

More information

Useful Medications for Oral Conditions *

Useful Medications for Oral Conditions * Useful Medications for Oral Conditions * DISCLAIMER: Drug information is constantly changing and is often subject to interpretation. While care has been taken to ensure the accuracy of the information

More information

5 MUSCULOSKELETAL SYSTEM

5 MUSCULOSKELETAL SYSTEM 5 MUSCULOSKELETAL SYSTEM 5.01 NON-STEROIDAL ANTIILAMMATORY DRUGS (NSAIDS) *Acetylsalicylic Acid (Aspirin) Tab Soluble 300mg Diclofenac Sodium Tab 25mg, Supp 25mg, 50mg & 100mg (Voltaren) 300-900mg every

More information

2015 Edition. Trust Medicines Formulary

2015 Edition. Trust Medicines Formulary 2015 Edition Trust Medicines Formulary Introduction Trust Medicines Formulary This formulary summarises all medicines used within the Trust, the Trust defines medicines as any substance, controlled or

More information

MORPHINE ADMINISTRATION

MORPHINE ADMINISTRATION Introduction Individualised Administration Drug of Choice Route of Administration & Doses Monitoring of Neonates & high risk patients Team Management Responsibility Morphine Protocol Flow Chart Introduction

More information

DRUGS FOR VIVA. IAP UG Teaching slides

DRUGS FOR VIVA. IAP UG Teaching slides DRUGS FOR VIVA 1 Q:1 INJ SODIUM BICARBONATE 1. What all strengths are available? 2. What are the clinical indications for IV sodium bicarbonate? 3. How do you administer this drug? 2 ANS: 1. Available

More information

WHO Model List (revised April 2002)

WHO Model List (revised April 2002) Essential Medicines Explanatory Notes The complementary list presents essential medicines for priority diseases which are efficacious, safe and cost-effective but not necessarily affordable, or for which

More information

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy Trust Approved Drugs List March 2016 The following is the list of drugs that are approved by the EEAST Medicines Management Group for use by EEAST clinical staff. Pharmacies are advised that this is the

More information

Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs)

Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs) Analgesics Opioid Analgesics, Long-acting fentanyl 100 mcg/hr patch td72 morphine sulfate 30 mg tablet er Opioid Analgesics, Short-acting fentanyl citrate 200 mcg lozenge hd hydrocodone/acetaminophen 5

More information

STATUTORY INSTRUMENTS. S.I. No. 300 of 2014 MEDICINAL PRODUCTS (PRESCRIPTION AND CONTROL OF SUPPLY) (AMENDMENT) REGULATIONS 2014

STATUTORY INSTRUMENTS. S.I. No. 300 of 2014 MEDICINAL PRODUCTS (PRESCRIPTION AND CONTROL OF SUPPLY) (AMENDMENT) REGULATIONS 2014 STATUTORY INSTRUMENTS. S.I. No. 300 of 2014 MEDICINAL PRODUCTS (PRESCRIPTION AND CONTROL OF SUPPLY) (AMENDMENT) REGULATIONS 2014 2 [300] S.I. No. 300 of 2014 MEDICINAL PRODUCTS (PRESCRIPTION AND CONTROL

More information

Medicines recommended to prevent and manage the priority diseases at the community and health facility level

Medicines recommended to prevent and manage the priority diseases at the community and health facility level s recommended to prevent and manage the priority diseases at the community and health facility level Shamim Qazi Department of Child and Adolescent Health and Development Global Causes of Child Deaths

More information

Rajasthan Medical Services Corporation Limited, Jaipur

Rajasthan Medical Services Corporation Limited, Jaipur Rajasthan Medical Services Corporation Limited, Jaipur List of Drugs- Purchase order placed to successful Bidders Tendered on 05/07/2011 S.No. Name of Drug 1 Atropine Sulphate Injection 0.6 mg /ml (SC/IM/IV

More information

Paramedic Pediatric Medical Math Practice

Paramedic Pediatric Medical Math Practice Paramedic Pediatric Medical Math Practice Name: Date: Problem 1 Your 4 year old patient weighs 40 pounds. She is febrile. You need to administer acetaminophen (Tylenol) 15mg/kg. How many mg will you administer?

More information

PACKAGE INSERT TEMPLATE FOR PARACETAMOL SUPPOSITORIES

PACKAGE INSERT TEMPLATE FOR PARACETAMOL SUPPOSITORIES PACKAGE INSERT TEMPLATE FOR PARACETAMOL SUPPOSITORIES Brand or Product Name [Product name] Suppositories mg Name and Strength of Active Substance(s) Eg Paracetamol 500mg Paracetamol 250mg Paracetamol 125mg

More information

NEWBORN EMERGENCY TRANSPORT SERVICE MEDICAL GUIDELINES

NEWBORN EMERGENCY TRANSPORT SERVICE MEDICAL GUIDELINES WOMEN AND NEWBORN HEALTH SERVICE King Edward Memorial Hospital NEWBORN EMERGENCY TRANSPORT SERVICE MEDICAL GUIDELINES Transport Medication List Title of policy: Transport Medication List Date Revised:

More information

Core Safety Profile. Pharmaceutical form(s)/strength: 5mg/ml and 25 mg/ml, Solution for injection, IM/IV FI/H/PSUR/0010/002 Date of FAR:

Core Safety Profile. Pharmaceutical form(s)/strength: 5mg/ml and 25 mg/ml, Solution for injection, IM/IV FI/H/PSUR/0010/002 Date of FAR: Core Safety Profile Active substance: Esketamine Pharmaceutical form(s)/strength: 5mg/ml and 25 mg/ml, Solution for injection, IM/IV P-RMS: FI/H/PSUR/0010/002 Date of FAR: 29.05.2012 4.3 Contraindications

More information

CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs

CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs page 1 CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs 2011 The following categories are included in this work programme: 1. Medicines

More information

PAIN PODCAST SHOW NOTES:

PAIN PODCAST SHOW NOTES: PAIN PODCAST SHOW NOTES: Dallas Holladay, DO Ultrasound Fellow Cook County Hospital Rush University Medical Center Jonathan D. Alterie, DO PGY-2, Emergency Medicine Midwestern University An overview of

More information

Resuscitation Fluids

Resuscitation Fluids Resuscitation Fluids Acceptable Fluids (also known as): Sodium Chloride Hartmann s Solution (Ringer-Lactate Solution, Compound Sodium Lactate) 4.5% Albumin Solution (PPS) Gelofusine 20ml/kg Bolus Can be

More information

Priority essential medicines: identifying products. Dr Suzanne Hill September 2010

Priority essential medicines: identifying products. Dr Suzanne Hill September 2010 Priority essential medicines: identifying products Dr Suzanne Hill September 2010 The problem looks like this Robertson, Forte, Trapsida & Hill. Bull WHO 2009 Robertson, Forte, Trapsida & Hill. Bull WHO

More information

Appendix 1: Interactions

Appendix 1: Interactions Appendix 1: Interactions Two or more drugs given at the same time may interact with each other. The interaction may be potentiation or antagonism of one drug by another, or occasionally some other. Drug

More information

Administration and Supply of Emergency Medicines

Administration and Supply of Emergency Medicines APPENDIX WHO CAN GIVE WHAT? Administration and Supply of Emergency Clinician Authorisation Key to Exemptions from legislation: NPP Non Parenteral POM. Can be given according to a protocol. 7 HMR 0, Schedule

More information

Appendix 5: Hepatic impairment

Appendix 5: Hepatic impairment Appendix 5: Hepatic impairment Liver disease may alter the response to drugs. However, the hepatic reserve appears to be large and liver disease has to be severe before important changes in drug metabolism

More information

A Nondepolarizing Neuromuscular Blocking (NMB) Agent

A Nondepolarizing Neuromuscular Blocking (NMB) Agent DOSING GUIDE A Nondepolarizing Neuromuscular Blocking (NMB) Agent Easy to remember dosing for the 0.20 mg/kg adult intubating doses of NIMBEX 1 *: For every 10 kg, give 1 ml of NIMBEX (2 mg/ml concentration)

More information

poor solubility and poor permeability unknown whether poor BA is due to poor solubility or antiglaucoma medicine for biowaiver Not eligible

poor solubility and poor permeability unknown whether poor BA is due to poor solubility or antiglaucoma medicine for biowaiver Not eligible Table 1 Substances on the WHO Model List of Essential Medicines (EML) Medicine a abacavir 200 mg high low 3 9.2.1.2 antiretroviral acetazolamide 250 mg low low (?) 4/2 antiglaucoma acetylsalicylic acid

More information

Useful Medications for Oral Conditions *

Useful Medications for Oral Conditions * AMERICAN ACADEMY OF PEDIATRIC DENTISTRY Useful Medications for Oral Conditions * DISCLAIMER: Drug information is constantly changing and is often subject to interpretation. While care has been taken to

More information

LET - Maths, Stats & Numeracy

LET - Maths, Stats & Numeracy Metric Conversions Here are some metric weights arranged in size order, starting with the biggest:- Kg (kilogram) g (gram) mg (milligram) mcg (microgram) Each one is a thousand (1000) times smaller than

More information

MODULE 1 SUPPORT MATERIALS

MODULE 1 SUPPORT MATERIALS MODULE 1 INTRODUCTION JOB AIDS AND SUPPORT MATERIALS Training Course on Inpatient Management of Severe Acute Malnutrition (Adapted from the 2002 WHO Training course on the inpatient management of severe

More information

Surgical Care at the District Hospital. EMERGENCY & ESSENTIAL SURGICAL CARE

Surgical Care at the District Hospital. EMERGENCY & ESSENTIAL SURGICAL CARE Surgical Care at the District Hospital 1 14 Practical Anesthesia Key Points 2 14.1 General Anesthesia Have a clear plan before starting anesthesia Never use an unfamiliar anesthetic technique in an emergency

More information

ASSESSMENT OF THE PAEDIATRIC NEEDS ANAESTHESIOLOGY DISCLAIMER

ASSESSMENT OF THE PAEDIATRIC NEEDS ANAESTHESIOLOGY DISCLAIMER European Medicines Agency Evaluation of Medicines for Human Use ASSESSMENT OF THE PAEDIATRIC NEEDS ANAESTHESIOLOGY London, October 2006 Doc. Ref: EMEA/405166/2006 DISCLAIMER The Paediatric Working Party

More information

Drugs, Supplies, Lab Tests and Materials Used in Post-Abortion Care

Drugs, Supplies, Lab Tests and Materials Used in Post-Abortion Care A. Complication: Shock [: Restoration of Fluids] 1. Management of respiration Oxygen 100 l 4.5 1 1 450 l 1 hour at 6-8l/minute (450 litres) 2. Control of bleeding Ergometrine tablets Ergometrine injection

More information

CHANGES FOR DECEMBER 2008 PREHOSPITAL CARE MANUAL

CHANGES FOR DECEMBER 2008 PREHOSPITAL CARE MANUAL CHANGES FOR DECEMBER 2008 PREHOSPITAL CARE MANUAL Item Changed Airway Management Procedure Oral Intubation Procedure Tube Confirmation and Monitoring Procedure C10 Chest Pain/ACS M2 Allergic Reaction/Anaphylaxis

More information

Antiallergics and drugs used in anaphylaxis

Antiallergics and drugs used in anaphylaxis Antiallergics and drugs used in anaphylaxis Antiallergics and drugs used in anaphylaxis The H 1 -receptor antagonists are generally referred to as antihistamines. They inhibit the wheal, pruritus, sneezing

More information

Understanding your take home medications from the surgical ward. Information for Patients

Understanding your take home medications from the surgical ward. Information for Patients Understanding your take home medications from the surgical ward Information for Patients i Information for Patients Please read this leaflet before taking the medications that have been prescribed for

More information

ADULT (>16) ACUTE SICKLE PAIN GUIDELINE

ADULT (>16) ACUTE SICKLE PAIN GUIDELINE ADULT (>16) ACUTE SICKLE PAIN GUIDELINE ID 2013 065 Author s Name Dr Anna Wood Author s Job Title Consultant Haematologist Division Consultant Haematologist Department Haematology Version number 3 Ratifying

More information

ADENOSINE. ADRENALINE (Epinephrine)

ADENOSINE. ADRENALINE (Epinephrine) ADENOSINE Notes Arrhythmias I.V. Initial dose 150 micrograms/kg stat Increase dose if required by 50 micrograms/kg to a maximum of 300 micrograms/kg (or 500 micrograms/kg if over 28 days old) ADMINISTRATION

More information

Appendix 4: Renal impairment

Appendix 4: Renal impairment Appendix 4: Renal impairment Reduced renal function may cause problems with drug therapy for the following reasons: 1. The failure to excrete a drug or its metabolites may produce toxicity. 2. The to some

More information

CONTENTS SECTION 1 SECTION

CONTENTS SECTION 1 SECTION CONTENTS SECTION 1 Foundations of Drug Therapy 1 CHAPTER 1 Introduction to Pharmacology 3 A Message to Students 3 Pharmacology and Drug Therapy 3 Understanding Grouping and Naming of Drugs 4 Prescription

More information

DBL NALOXONE HYDROCHLORIDE INJECTION USP

DBL NALOXONE HYDROCHLORIDE INJECTION USP Name of medicine Naloxone hydrochloride Data Sheet New Zealand DBL NALXNE HYDRCHLRIDE INJECTIN USP Presentation DBL Naloxone Hydrochloride Injection USP is a sterile, clear, colourless solution, free from

More information

In our patients the cause of seizures can be broadly divided into structural and systemic causes.

In our patients the cause of seizures can be broadly divided into structural and systemic causes. Guidelines for the management of Seizures Amalgamation and update of previous policies 7 (Seizure guidelines, ND, 2015) and 9 (Status epilepticus, KJ, 2011) Seizures can occur in up to 15% of the Palliative

More information

CMI Marketplace 2015 (List of Covered Drugs)

CMI Marketplace 2015 (List of Covered Drugs) Analgesics Opioid Analgesics, Long-acting fentanyl 100 mcg/hr patch td72 fentanyl citrate 200 mcg lozenge hd morphine sulfate 30 mg tablet er oxymorphone hcl 7.5 mg tab er 12h Opioid Analgesics, Short-acting

More information

Operational Guide for School Oral Health Program. Prescribing Medicine

Operational Guide for School Oral Health Program. Prescribing Medicine Prescribing Clinical Protocols Medicine Operational Guide for School Oral Health Program Prescribing Medicine 107 Prescribing Medicine 43, 44, 45 The Kuwait drug index is the only authoritative source

More information

Guideline for the Management of Continuous IV Vancomycin Infusion in Neonates on NICU A Clinical Guideline recommended for use

Guideline for the Management of Continuous IV Vancomycin Infusion in Neonates on NICU A Clinical Guideline recommended for use Guideline for the Management of Continuous IV Vancomycin Infusion in A Clinical Guideline recommended for use For Use in: By: For: Division responsible for document: Key words: Name and job title of document

More information

Pharmacology. An Introduction. Henry Hitner, Ph.D. Barbara Nagle, Ph.D. Learn. Neuroscience, Physiology,

Pharmacology. An Introduction. Henry Hitner, Ph.D. Barbara Nagle, Ph.D. Learn. Neuroscience, Physiology, Pharmacology An Introduction Henry Hitner, Ph.D. Department Neuroscience, Physiology, Philadelphia College of Osteopathie Medicine Philadelphia, Pennsylvania Adjunct Professor, Pharmacology Physician Assistant

More information

Pharmacotherapy Issues in the Pediatric Population

Pharmacotherapy Issues in the Pediatric Population Pharmacotherapy Issues in the Pediatric Population Continuing Professional Pharmacy Development Dr. Shane Pawluk, PharmD Dr. Andrea Cartwright, PharmD Dr. Maryam Khaja March 26, 2014 Outline Didactic Session

More information

July Formulary Policy

July Formulary Policy Formulary Policy July 2017 Responsible Committee: Quality Committee Date Effective: July 2017 Author: Rahinatu Amadu Supersedes: July 2016 Next Review Due: July 2018 Formulary Policy 2016-2018 1. INTRODUCTION

More information

Are Pediatric Patients Small Adults?

Are Pediatric Patients Small Adults? Are Pediatric Patients Small Adults? Maria Paulina Duarte, Pharm.D. PGY-1 Pharmacy Resident Mercy Hospital A Campus of Plantation General Hospital Goals and Objectives Understand the history and evolution

More information

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL If a patient is believed to be approaching the end of their life, medication should be prescribed in anticipation

More information

Syringe driver in Palliative Care

Syringe driver in Palliative Care Syringe driver in Palliative Care Introduction: Syringe drivers are portable, battery operated devices widely used in palliative care to deliver medication as a continuous subcutaneous infusion over 24

More information

Ideal Sedative Agent. Benzodiazepines 11/12/2013. Pharmacology of Benzodiazepines Used for Conscious Sedation in Dentistry.

Ideal Sedative Agent. Benzodiazepines 11/12/2013. Pharmacology of Benzodiazepines Used for Conscious Sedation in Dentistry. Pharmacology of Benzodiazepines Used for Conscious Sedation in Dentistry Peter Walker Ideal Sedative Agent Anxiolysis Analgesic No effect on CVS No effect on respiratory system Not metabolised Easy and

More information

Ideal Sedative Agent. Pharmacokinetics. Benzodiazepines. Pharmacodynamics 11/11/2013

Ideal Sedative Agent. Pharmacokinetics. Benzodiazepines. Pharmacodynamics 11/11/2013 Ideal Sedative Agent Pharmacology of Benzodiazepines Used for Conscious Sedation in Dentistry Peter Walker Anxiolysis Analgesic No effect on CVS No effect on respiratory system Not metabolised Easy and

More information

EXPRESSION OF INTEREST SUPPLY OF MEDICINES FOR THE GOVERNMENT OF FIJI FREE MEDICINE INITIATIVE

EXPRESSION OF INTEREST SUPPLY OF MEDICINES FOR THE GOVERNMENT OF FIJI FREE MEDICINE INITIATIVE EXPRESSION OF INTEREST SUPPLY OF MEDICINES FOR THE GOVERNMENT OF FIJI FREE MEDICINE INITIATIVE The Fijian Government invites expressions of interest from reputable Manufacturers and Suppliers for the supply

More information

Atropine Sulfate Injection

Atropine Sulfate Injection http://www.ashp.org/menu/practicepolicy/resourcecenters/drugshortages/currentshortages.aspx Atropine Sulfate Injection [10 April 2012] Atropine injection, Hospira 0.05 mg/ml, 5 ml Ansyr syringe, package

More information

Pain management in Paediatric Palliative Care. Dr Jane Nakawesi 14 th August 2017

Pain management in Paediatric Palliative Care. Dr Jane Nakawesi 14 th August 2017 Pain management in Paediatric Palliative Care Dr Jane Nakawesi 14 th August 2017 Content Management of pain in children Non pharmacological Pharmacological Exit level outcomes The participants will: Know

More information

ANTIBIOTIC GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED MENINGITIS AND ENCEPHALITIS IN ADULTS

ANTIBIOTIC GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED MENINGITIS AND ENCEPHALITIS IN ADULTS ANTIBIOTIC GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED MENINGITIS AND ENCEPHALITIS IN ADULTS Version 4.0 Date ratified February 2009 Review date February 2011 Ratified by Authors Consultation Evidence

More information

M0BCore Safety Profile

M0BCore Safety Profile M0BCore Safety Profile Active substance: Aciclovir Pharmaceutical form(s)/strength: Tablets 200, 400 or 800 mg Dispersible tablets 200, 400 or 800 mg Oral suspensions 200 mg or 400 mg per 5 ml. Freeze

More information

LIST OF PRODUCTS INJECTIONS DRY POWDER INJECTIONS & LIQUID INJECTIONS. Therapeutic Segment. S.No Name Form Pharmacope

LIST OF PRODUCTS INJECTIONS DRY POWDER INJECTIONS & LIQUID INJECTIONS. Therapeutic Segment. S.No Name Form Pharmacope LIST OF PRODUCTS S.No Name Form Pharmacope ia Strength Therapeutic Segment ECTIONS DRY POWDER ECTIONS & LIQUID ECTIONS 1 a b Arteether 75mg/ml 150 mg/2ml & 225 mg/3ml 2 Amikacin Sulfate IP/ 100/250/500

More information

Antimicrobial Management of Febrile Neutropenic Sepsis

Antimicrobial Management of Febrile Neutropenic Sepsis Antimicrobial Management of Febrile Neutropenic Sepsis Written by: Dr J Joseph, Consultant Haematologist Dr K Gajee, Consultant Microbiologist Amended by: Larissa Claybourn, Antimicrobial Pharmacist Date:

More information

STARSHIP WITHDRAWAL OF ANALGESIA AND SEDATION

STARSHIP WITHDRAWAL OF ANALGESIA AND SEDATION STARSHIP WITHDRAWAL OF ANALGESIA AND SEDATION Patients receiving analgesia and/or sedation for longer than 5-7 days may suffer withdrawal if these drugs are suddenly stopped. To prevent this happening

More information

** Medication exercises ** NICU Phase II

** Medication exercises ** NICU Phase II ** Medication exercises ** NICU Phase II A) Baby A has had a bowel resection six hours ago. She weighs 3 kg. Post-op, she is quite agitated and she is on a fentanyl drip at 2 micrograms/kg/hr (#1). She

More information

Care in the Last Days of Life

Care in the Last Days of Life Care in the Last Days of Life Introduction This guideline is an aid to clinical decision making and good practice in person-centred care for patients who are deteriorating and at risk of dying. The patient

More information

Clarity around the new editions of the BNF Publications

Clarity around the new editions of the BNF Publications Clarity around the new editions of the BNF Publications UKMi, the Neonatal and Paediatrics Pharmacy Group (NPPG) and the BNF are aware of a number of discussions and email threads discussing BNF for Children

More information

Analgesic-Sedatives Drug Dose Onset

Analgesic-Sedatives Drug Dose Onset Table 4. Commonly used medications in procedural sedation and analgesia Analgesic-Sedatives Fentanyl Morphine IV: 1-2 mcg/kg Titrate 1 mcg/kg q3-5 minutes prn IN: 2 mcg/kg Nebulized: 3 mcg/kg IV: 0.05-0.15

More information

BJF Acute Pain Team Formulary Group

BJF Acute Pain Team Formulary Group Title Analgesia Guidelines for Acute Pain Management (Adults) in BGH Document Type Issue no Clinical guideline Clinical Governance Support Team Use Issue date April 2013 Review date April 2015 Distribution

More information

PEDIATRIC EMERGENCY CARE GUIDE Child 70mm. Child 70mm

PEDIATRIC EMERGENCY CARE GUIDE Child 70mm. Child 70mm PEDIATRIC EMERGENCY CARE GUIDE Pediatric Parameters & Equipment Age Neonate 3mo 6mo 1 yr 2 yr 3 yr 4 yr 6 yr 8 yr 12 yr 14 yr Wt (kg) 3.5 6 8 10 12 14 16 20 25 40 50 ~ BSA (m 2 ) 0.24 0.34 0.42 0.49 0.56

More information

Dsuvia (sufentanil) NEW PRODUCT SLIDESHOW

Dsuvia (sufentanil) NEW PRODUCT SLIDESHOW Dsuvia (sufentanil) NEW PRODUCT SLIDESHOW Introduction Brand name: Dsuvia Generic name: Sufentanil Pharmacological class: Opioid agonist Strength and Formulation: 30mcg; sublingual tabs (housed in a disposable,

More information

Purpose of the Guideline

Purpose of the Guideline Trust Policy and Procedure Substitution of Medicines Policy Document ref. no: PP(17)210 For use in: For use by: For use for: Document owner: Status: All clinical areas Pharmacists and authorised Pharmacy

More information

Medication Calculation Practice Problems

Medication Calculation Practice Problems Medication Calculation Practice Problems Below is a section of the list of medications that are programmed in the Alaris IV Pump s Guardrail Drug Library. During your orientation you will learn more about

More information

FOR REPRESENTATIVE EDUCATION

FOR REPRESENTATIVE EDUCATION Neuromuscular Blockade in the ICU NIMBEX Indication 1 NIMBEX (cisatracurium besylate) is indicated as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients

More information

Adult Drug Reference. Dopamine Drip Chart. Pediatric Drug Reference. Pediatric Drug Dosage Charts DRUG REFERENCES

Adult Drug Reference. Dopamine Drip Chart. Pediatric Drug Reference. Pediatric Drug Dosage Charts DRUG REFERENCES Adult Drug Reference Dopamine Drip Chart Pediatric Drug Reference Pediatric Drug Dosage Charts DRUG REFERENCES ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments ADENOSINE Paroxysmal

More information

PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain

PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain Index No: MMG43 PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain Version: 3.1 (Includes anti-emetics and naloxone) Date ratified: July 2013 Ratified by: (Name of Committee) Name

More information

Core Safety Profile. Pharmaceutical form(s)/strength: Solution for Injection CZ/H/PSUR/0005/002 Date of FAR:

Core Safety Profile. Pharmaceutical form(s)/strength: Solution for Injection CZ/H/PSUR/0005/002 Date of FAR: Core Safety Profile Active substance: Rocuronium bromide Pharmaceutical form(s)/strength: Solution for Injection P-RMS: CZ/H/PSUR/0005/002 Date of FAR: 31.05.2012 4.3 Contraindications Hypersensitivity

More information

Pediatric Compounding. Erika Fallon, PharmD/RPh

Pediatric Compounding. Erika Fallon, PharmD/RPh Pediatric Compounding Erika Fallon, PharmD/RPh Disclosure I, Erika Fallon, declare no conflicts of interest, real or apparent, and no financial interests in any company, product, or service mentioned in

More information

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care If possible patients should be assessed using a simple visual analogue scale VAS to determine the most appropriate stage

More information

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and 5 Infections To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and Southend University Hospital, Antibiotic Guidelines Index 5.1 Antibacterial drugs

More information

POSTOPERATIVE PAIN RELIEF

POSTOPERATIVE PAIN RELIEF POSTOPERATIVE PAIN RELIEF Caesarean sections are equal to laparotomies in many aspects, pain relief not an exception. The widespread use of spinal anaesthesia often lends to the mistaken belief that these

More information

Algorithms for Symptom Management. In End of Life Care

Algorithms for Symptom Management. In End of Life Care Algorithms for Symptom Management In End of Life Care The Use of Drugs Beyond Licence (off label) -The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK regulates the activity of the

More information

PICU BRONCHIOLITIS PLAN

PICU BRONCHIOLITIS PLAN PICU BRONCHIOLITIS PLAN Diagnosis Weight PHYSICIAN S Allergies Admit/Discharge/Transfer Patient Status Pt Status: Inpatient (LOS > 2 midnights) Pt Status: Observation (LOS < 2 midnights) Patient Care Code

More information

TRAPADOL INJECTION FOR I.V./I.M. USE ONLY

TRAPADOL INJECTION FOR I.V./I.M. USE ONLY TRAPADOL INJECTION FOR I.V./I.M. USE ONLY Composition : Each 2ml. contains : Tramadol Hydrochloride I.P. Water for injection I.P. 100mg. q.s. CLINICAL PHARMACOLOGY : Pharmacodynamics Tramadol is a centrally

More information

Magnesium Sulphate - Management of Hypertensive Disorders of Pregnancy

Magnesium Sulphate - Management of Hypertensive Disorders of Pregnancy 1. Purpose Magnesium sulphate is the anticonvulsant of choice for pre-eclampsia prophylaxis and treatment. This clinical guideline outlines the indications, contraindications, administration and monitoring

More information

Drug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe)

Drug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe) Drug Max dose approved for IVP Dilution Rate Monitoring Parameters Acetazolamide 500 mg Reconstitute with at least 5ml sterile water (max concentration should not exceed 100mg/ml) 100-500 mg/min Hypotension

More information

BACKGROUND Measuring renal function :

BACKGROUND Measuring renal function : A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal

More information

Cardiac Catheter Labs Intravenous Drug Therapy Guide

Cardiac Catheter Labs Intravenous Drug Therapy Guide Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Cardiac Catheter Lab IV Medicines Guideline Helen Buxton ( Senior Cath Lab

More information

PHAR 7632 Chapter 7. Table Market and Share of Pharmaceuticals by ROA Data from Viswanathan, 2004

PHAR 7632 Chapter 7. Table Market and Share of Pharmaceuticals by ROA Data from Viswanathan, 2004 Student Objectives for this Chapter After completing the material in this chapter each student should:- be able to describe various routes of drug administration including the concentration versus time

More information

Acute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a)

Acute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a) Acute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a) Introduction The majority of acute painful crises in patients with sickle cell disease will be managed independently

More information

IMDG CODE Poison Treatment Chest

IMDG CODE Poison Treatment Chest 2018 IMDG CODE Poison Treatment Chest This document contains the complete list of medicines and medical supplies for the vessels poison treatment chest and is based on the IMDG code international maritime

More information

Chapter 19. Media Directory. Topical (Surface) Anesthesia. Spinal Anesthesia. Nerve-Block Anesthesia. Infiltration (Field-Block) Anesthesia

Chapter 19. Media Directory. Topical (Surface) Anesthesia. Spinal Anesthesia. Nerve-Block Anesthesia. Infiltration (Field-Block) Anesthesia Chapter 19 Drugs for Local and General Anesthesia Slide 18 Media Directory Lidocaine Animation Upper Saddle River, New Jersey 07458 All rights reserved. Topical (Surface) Anesthesia Creams, sprays, suppositories

More information

Goals for sedation during mechanical ventilation

Goals for sedation during mechanical ventilation New Uses of Old Medications Gina Riggi, PharmD, BCCCP, BCPS Clinical Pharmacist Trauma ICU Jackson Memorial Hospital Disclosure I do not have anything to disclose Objectives Describe the use of ketamine

More information

ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments

ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments ADENOSINE Paroxysmal SVT 1 st Dose 6 mg rapid IV 2 nd & 3 rd Doses 12 mg rapid IV push Follow each dose with rapid bolus of 20 ml NS May cause transient heart block or asystole. Side effects include chest

More information

Drug Therapy Following Bariatric Surgery

Drug Therapy Following Bariatric Surgery Drug Therapy Following Bariatric Surgery Linda F. McElhiney PharmD, RPh, MSP, FIACP, FACA, FASHP, DPLA Compounding Pharmacist Indiana University Health Disclosures Dr. McElhiney declare(s) no conflicts

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Tralieve 50 mg/ml solution for injection for dogs (AT, BE, BG, CY, CZ, DE, EL, ES, HR, HU, IE, IT, LU, NL, PT, RO,

More information

OFFERâ S INJECTABLES

OFFERâ S INJECTABLES A B Page 6 7 8 9 0 C 6 7 Page 8 9 0 D E Page 6 7 8 9 F Page 6 7 8 9 G H Page 6 7 8 9 I 6 7 Page 6 8 9 0 J 6 7 Page 7 K 6 7 8 9 L Page 8 6 7 8 9 0 Page 9 6 7 8 9 0 Page 0 OFFERâ S INJECTABLES Alimentary

More information

PICU Therapeutic Hypothermia Post Cardiac Arrest Re Warming Phase

PICU Therapeutic Hypothermia Post Cardiac Arrest Re Warming Phase Arrest Re Warming Phase Weight Allergies Patient Care ***After 24 hours initiate re warming (or after 72 hours for an infant less than one month old)*** PICU Re Warming Protocol ***See Reference Text***

More information

IMDG CODE Poison Treatment Chest

IMDG CODE Poison Treatment Chest 2017 IMDG CODE Poison Treatment Chest This document contains the complete list of medicines and medical supplies for the vessels poison treatment chest and is based on the IMDG code international maritime

More information

Elite Pharma (Pvt.) Ltd., Lahore Pakistan (Injectables)

Elite Pharma (Pvt.) Ltd., Lahore Pakistan (Injectables) 1 022237 Aqua Elite Water for Injection 5ml 100 x 5ml 2 022238 Neuro -S (Each 3ml contains: B1 + B6 + B12) Vitamins 25 x 3ml 5 x 3ml 100 x 3ml 4 024864 Elusen (Frusemide --- 20mg / 2ml] Diuretic 50 x 2ml

More information

Panadeine Tablet, Caplets and Rapid Soluble tablets PRODUCT INFORMATION

Panadeine Tablet, Caplets and Rapid Soluble tablets PRODUCT INFORMATION Panadeine Tablet, Caplets and Rapid Soluble tablets PRODUCT INFORMATION DESCRIPTION Active Ingredients Paracetamol 500 mg Codeine Phosphate 8 mg Excipients Tablets - Starch - maize, talc - purified, stearic

More information

Statutory Instrument. S.I. No. 510 of Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations 2005

Statutory Instrument. S.I. No. 510 of Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations 2005 Statutory Instrument S.I. No. 510 of 2005 Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations 2005 PUBLISHED BY THE STATIONERY OFFICE, DUBLIN To be purchased directly from the

More information

WEIGHT: KG HEIGHT: CM ALLERGY CAUTION sheet reviewed Code Status Full code

WEIGHT: KG HEIGHT: CM ALLERGY CAUTION sheet reviewed Code Status Full code (Page 1 of 5) Code Status Full code Status/Admit/Transfer/Discharge Surgical Procedure(s) and date performed: Cardiologist: Cardiac Surgeon: Intensivist: Patient Care CMV status Recipient CMV status Donor

More information

90-Day Generic Drug Discount List Treatment Medication Strength Dose Quantity Price Allergy/Cold&Flu Benzonatate 100mg Tablet 42 $15.

90-Day Generic Drug Discount List Treatment Medication Strength Dose Quantity Price Allergy/Cold&Flu Benzonatate 100mg Tablet 42 $15. 90-Day Generic Drug Discount List Treatment Medication Strength Dose Quantity Price Allergy/Cold&Flu Benzonatate 100mg Tablet 42 $15.00 Allergy/Cold&Flu C-Phen Drops n/a Drops 90 $15.00 Allergy/Cold&Flu

More information